A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.

NCT07199257 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis, Seasonal

Interventions

BIOLOGICAL: GR1802 injection
BIOLOGICAL: Placebo

Sponsor

Genrix (Shanghai) Biopharmaceutical Co., Ltd.